Chen Q, Wu R, Zhang C, Xie J, et al. Efficacy and safety of tislelizumab plus intravesical chemotherapy in recurrent high-risk non-muscle-invasive bladder cancer: A retrospective single-center real-world study. Urol Oncol 2026;44:110988.
PMID: 41579586